Recent RMA Investigations
Chronic Lymphoid Leukaemia
Following the investigation relating to “dioxin exposure” and “dioxin contaminated herbicide exposure” the Repatriation Medical Authority (RMA) has declared that it does not propose to amend the Statement of Principles (SoPs) concerning Chronic Lymphoid Leukaemia Nos. 9 & 10 of 2005.
The RMA considered that the new sound medical scientific evidence available was not sufficient to justify an amendment to the SoPs already determined in respect of Chronic Lymphoid Leukaemia.
New Investigations
The RMA has given notice that it intends to carry out investigations in respect of the following:
- Bronchiolitis obliterans organising pneumonia (a new condition);
- Tension-type headache (Nos. 76 & 77 of 1999);
- Trigeminal neuropathy (Nos. 81 of 1995, as amended by 11 of 2002 & 82 of 1995); and
- Malignant neoplasm of the eye (Nos. 1 and 2 of 1997).
All submissions must be received by the RMA at the address below no later than 21 July 2008. For persons and organisations wishing to make a submission, a copy of the notice and submission guidelines are available at www.rma.gov.au.
The Repatriation Medical Authority
8th Floor, 259 Queen Street
[GPO Box 1014]
BRISBANE QLD 4001
Telephone: (07) 3815 9404